CA1016946A - 3,-4-dihydropyridones - Google Patents
3,-4-dihydropyridonesInfo
- Publication number
- CA1016946A CA1016946A CA179,509A CA179509A CA1016946A CA 1016946 A CA1016946 A CA 1016946A CA 179509 A CA179509 A CA 179509A CA 1016946 A CA1016946 A CA 1016946A
- Authority
- CA
- Canada
- Prior art keywords
- dihydropyridones
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pulmonology (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Quinoline Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2242787A DE2242787C2 (de) | 1972-08-31 | 1972-08-31 | 4-Phenyl-6-amino-3,4-dihydropyridon-(2)-3,5-dicarbonsäure-diäthylesterderivate, ein Verfahren zu deren Herstellung und diese enthaltende Arzneimittel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1016946A true CA1016946A (en) | 1977-09-06 |
Family
ID=5855065
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA179,509A Expired CA1016946A (en) | 1972-08-31 | 1973-08-23 | 3,-4-dihydropyridones |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US3925395A (OSRAM) |
| JP (1) | JPS5626661B2 (OSRAM) |
| AT (1) | AT327902B (OSRAM) |
| AU (1) | AU476373B2 (OSRAM) |
| BE (1) | BE804161A (OSRAM) |
| CA (1) | CA1016946A (OSRAM) |
| CH (1) | CH592061A5 (OSRAM) |
| DD (1) | DD109628A5 (OSRAM) |
| DE (1) | DE2242787C2 (OSRAM) |
| DK (1) | DK131855C (OSRAM) |
| ES (1) | ES418340A1 (OSRAM) |
| FR (1) | FR2197598B1 (OSRAM) |
| GB (1) | GB1389505A (OSRAM) |
| HU (1) | HU167992B (OSRAM) |
| IE (1) | IE38141B1 (OSRAM) |
| IL (1) | IL43080A (OSRAM) |
| LU (1) | LU68325A1 (OSRAM) |
| NL (1) | NL7311832A (OSRAM) |
| PL (1) | PL89430B1 (OSRAM) |
| SE (1) | SE385882B (OSRAM) |
| ZA (1) | ZA735973B (OSRAM) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4002762A (en) * | 1973-03-03 | 1977-01-11 | Bayer Aktiengesellschaft | 2-Amino-3,4-dihydropyridines used to effect coronary vessel dilation and treat hypertension |
| IT8367883A0 (it) * | 1982-08-23 | 1983-08-22 | Rorer Int Overseas | Composti cardiotonici del 2 piridone 5 biciclico eteroaril sostituito e relative composizioni farmaceutiche |
| WO1993009774A1 (en) * | 1991-11-18 | 1993-05-27 | G.D. Searle & Co. | 2-(4-substituted)phenylmethylene derivatives and methods of use |
| CA2496815C (en) | 2002-08-27 | 2011-04-26 | Bayer Healthcare Ag | Dihydropyridinone derivatives |
| US20050252833A1 (en) * | 2004-05-14 | 2005-11-17 | Doyle James A | Process and apparatus for converting oil shale or oil sand (tar sand) to oil |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1923990C3 (de) * | 1969-05-10 | 1978-11-23 | Bayer Ag | Verfahren zur Herstellung von N-substituierten M-Dihydropyridin-S.S-dicarbonsäureestern |
| DE2013431C3 (de) * | 1970-03-20 | 1979-12-20 | Bayer Ag, 5090 Leverkusen | 4-Azidophenyl-l,4-dihydropyridin-3,5-dicarbonsäureester |
| DE2003146A1 (de) * | 1970-01-24 | 1971-07-29 | Bayer Ag | Neue 1,4-Dihydropyridinderivate |
-
1972
- 1972-08-31 DE DE2242787A patent/DE2242787C2/de not_active Expired
-
1973
- 1973-08-21 US US390193A patent/US3925395A/en not_active Expired - Lifetime
- 1973-08-23 CA CA179,509A patent/CA1016946A/en not_active Expired
- 1973-08-27 IL IL43080A patent/IL43080A/en unknown
- 1973-08-28 NL NL7311832A patent/NL7311832A/xx not_active Application Discontinuation
- 1973-08-29 BE BE135060A patent/BE804161A/xx unknown
- 1973-08-29 CH CH1238973A patent/CH592061A5/xx not_active IP Right Cessation
- 1973-08-29 JP JP9628973A patent/JPS5626661B2/ja not_active Expired
- 1973-08-29 PL PL1973164910A patent/PL89430B1/pl unknown
- 1973-08-29 DD DD173153A patent/DD109628A5/xx unknown
- 1973-08-29 LU LU68325A patent/LU68325A1/xx unknown
- 1973-08-30 SE SE7311813A patent/SE385882B/xx unknown
- 1973-08-30 GB GB4084873A patent/GB1389505A/en not_active Expired
- 1973-08-30 IE IE1524/73A patent/IE38141B1/xx unknown
- 1973-08-30 ES ES418340A patent/ES418340A1/es not_active Expired
- 1973-08-30 ZA ZA735973A patent/ZA735973B/xx unknown
- 1973-08-30 AU AU59835/73A patent/AU476373B2/en not_active Expired
- 1973-08-30 HU HUBA2976A patent/HU167992B/hu unknown
- 1973-08-30 DK DK476573*A patent/DK131855C/da active
- 1973-08-31 FR FR7331531A patent/FR2197598B1/fr not_active Expired
- 1973-08-31 AT AT760073A patent/AT327902B/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| PL89430B1 (OSRAM) | 1976-11-30 |
| FR2197598B1 (OSRAM) | 1977-07-15 |
| ES418340A1 (es) | 1976-03-16 |
| IE38141B1 (en) | 1978-01-04 |
| GB1389505A (en) | 1975-04-03 |
| DK131855B (da) | 1975-09-15 |
| DE2242787A1 (de) | 1974-03-14 |
| HU167992B (OSRAM) | 1976-02-28 |
| BE804161A (fr) | 1974-02-28 |
| IL43080A (en) | 1977-01-31 |
| JPS5626661B2 (OSRAM) | 1981-06-19 |
| AU476373B2 (en) | 1976-09-16 |
| ZA735973B (en) | 1974-10-30 |
| US3925395A (en) | 1975-12-09 |
| AU5983573A (en) | 1975-03-06 |
| FR2197598A1 (OSRAM) | 1974-03-29 |
| IL43080A0 (en) | 1973-11-28 |
| DD109628A5 (OSRAM) | 1974-11-12 |
| ATA760073A (de) | 1975-05-15 |
| IE38141L (en) | 1974-02-28 |
| AT327902B (de) | 1976-02-25 |
| DK131855C (da) | 1976-02-16 |
| SE385882B (sv) | 1976-07-26 |
| JPS4962483A (OSRAM) | 1974-06-17 |
| LU68325A1 (OSRAM) | 1973-10-30 |
| CH592061A5 (OSRAM) | 1977-10-14 |
| DE2242787C2 (de) | 1982-01-21 |
| NL7311832A (OSRAM) | 1974-03-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU462348B2 (en) | Saf-t-jet | |
| AU467469B2 (en) | Trifluoromethylmercaptoacetamindocephalosphorins | |
| AU454372B2 (en) | Childsafe actuator-overcap | |
| AU469305B2 (en) | Deipenylyl-alkanoylaminopyridine | |
| CA1019747A (en) | Anilinobenzothiazoles | |
| AU475339B2 (en) | S-substituted-2-thiodenosines | |
| AU475748B2 (en) | Napnthopyrans | |
| AU470359B2 (en) | Sulphamoylphenyl-imidazolidinones | |
| AU466344B2 (en) | Cycloalkyllactamimides | |
| AU468159B2 (en) | 5-aroyl-furans | |
| AU471369B2 (en) | Diphenylmethoxyethylamines | |
| AU468599B2 (en) | 15-oxasteroids | |
| AU467526B2 (en) | Pyronorifamycins | |
| AU468236B2 (en) | 2-acyl-5-nitrothiazoles | |
| AU473297B2 (en) | Indolylimidoylheterocyclics | |
| AU472554B2 (en) | Isothocyanobenzoxazoles | |
| CA979908A (en) | N-furylmethyl-2-arylaminoimidazolines-(2) | |
| AU482763B2 (en) | N-substituted-n'-aryloxycarbonformamidines | |
| CA912586A (en) | N-cycloalkenyl-n-aryl-n'-alkylureas | |
| CA917654A (en) | 4-v-triazolyl-4'-phenylstilbenes | |
| CA894806A (en) | 3'-substituted-2-hydroxy-3-naphthanilides | |
| AU5820773A (en) | 4&-aryl-trans-decahydroisoquinolines | |
| AU482051B2 (en) | l-PHENYL-4-PIPERAZINYL-CYCLOBUTANOL-(1) DERIVATIVES | |
| AU6074873A (en) | N-substituted-n'-aryloxycarbonformamidines | |
| AU477717B2 (en) | Bis-alkanolamines |